Network News

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

Basel, Switzerland / Köln, Germany August 12, 2026 The University Hospital Cologne (Universitätsklinikum Köln, UHC) has chosen the Celonic Group as its CDMO partner for advanced process development and GMP manufacturing of its monoclonal antibody targeting Pseudomonas aeruginosa, a Gram‑negative pathogen responsible for severe hospital‑acquired infections, biofilm‑driven persistence, and rising antimicrobial resistance. The antibody program is […]

Joint Press Release from NCT Heidelberg and Mannheim University Medical Center The National Center for Tumor Diseases (NCT) Heidelberg and the Mannheim Cancer Center (MCC) are receiving joint funding as a Center of Excellence in Oncology for the first time. German Cancer Aid is providing 4.8 million euros over four years for the new consortium. […]

Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Paris, August 4, 2026. Sanofi today announced that the European Commission (EC) has approved an extension of the indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vaccine) to include infants from six weeks of age […]

Merck opens a €25M testing facility at its Darmstadt headquarters, strengthening drug release testing for European biopharmaceutical markets. 16 Jul 2026 | Darmstadt, Germany Merck, a leading science and technology company, today opened a new €25 million BioReliance® testing facility at its global headquarters in Darmstadt, Germany. The facility expands access to commercial drug substance and drug product […]

The spin-off aims to develop a new generation of precision medicines using epigenome editing to precisely regulate gene expression without altering DNA A newly launched EMBL spin-off, Epitome Therapeutics, aims to translate pioneering research in epigenome editing into a new generation of precision medicines. Co-founded by EMBL Group Leader Jamie Hackett, the company builds on cutting-edge […]

The 2026 Meyenburg Prize goes to bioinformatician and systems biologist Aviv Regev, head of research at the biotech company Genentech in San Francisco, USA. The scientist is considered a pioneer of single-cell genomics, a method that allows for the high-resolution measurement and analysis of gene activity in individual cells—a field of research that has fundamentally […]

Basel, Switzerland / Martinsried, Germany – 28 July, 2026 Celonic AG, a Swiss-based biologics Contract Development and Manufacturing Organization (CDMO), and Leukocare AG, a leading provider of drug product development services, today announced a collaboration to support biopharmaceutical companies developing increasingly complex biologics. The collaboration brings together Celonic’s expertise in cell line development, drug substance […]